View By:
May 2 – 3
Improving Immunotherapy Efficacy and Safety
Characterization for Novel Biotherapeutics
Difficult-to-Express Proteins
Antibodies for Cancer Therapy
Display of Biologics
May 3 – 4
Cell-Based Immunotherapies
Biophysical Methods
Engineering Antibodies
Optimizing Protein Expression
Emerging Targets and Novel Approaches for Oncology & Beyond
Immunogenicity Assessment and Management
Advancing Bispecific Antibodies and Combination Therapy to the Clinic
May 5 – 6
Next Generation Immunotherapies
Gene Therapy R&D Analytics
Maximizing Protein Production Workflows
Driving Clinical Success in Antibody Drug Conjugates
Machine Learning Approaches for Protein Engineering
Engineering Bispecific Antibodies
